Literature DB >> 25470631

Age and gender differences in the clustering of metabolic syndrome combinations: A prospective cohort research from the Kerman Coronary Artery Disease Risk Study (KERCADRS).

Gholamreza Yousefzadeh1, Mehrdad Sheikhvatan2.   

Abstract

BACKGROUND: The features of metabolic syndrome (MetS) and its components are now different in Iran compared to western countries. AIMS: The aim of this study was to provide estimates of the prevalence of the different MetS combinations in younger and older men and women in Iran.
METHODS: A detailed interview regarding social demographics risk profile, and components of MetS was administered according to the Kerman Coronary Artery Disease Risk Study (KERCADRS) as population-based, epidemiological research among a cohort of 6000 individuals that residence in Kerman city.
RESULTS: The overall prevalence of MetS was 25.2% in men and 42.5% in women considering the International Diabetes Federation (IDF) criteria and 31.0% in men and 38.0% in women when the National Cholesterol Education Program (NCEP) definition was applied. MetS was significantly more prevalent in females, using both definitions. The prevalence of MetS increased with age in both gender when both syndrome criteria were considered. The prevalence of different combinations of the syndrome by both definitions peaked in the age range 51-60 years among both men and women. The appearance of each component was observed earlier in women than men.
CONCLUSION: The prevalence of the MetS in the State of Kerman, a great province in the south-east of Iran is estimated as 35.0%, higher than in most developed countries and some other Middle-East regions, with generally higher prevalence rates for women. The prevalence of MetS increases with age in both genders with earlier appearance in men. Crown
Copyright © 2013. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Age; Gender; Metabolic syndrome

Mesh:

Substances:

Year:  2013        PMID: 25470631     DOI: 10.1016/j.dsx.2013.02.023

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN: 1871-4021


  6 in total

Review 1.  Prevalence and Incidence of Metabolic Syndrome in Iran: A Systematic Review and Meta-Analysis.

Authors:  Azad Fatahi; Amin Doosti-Irani; Zahra Cheraghi
Journal:  Int J Prev Med       Date:  2020-06-03

2.  Determinants of metabolic syndrome among patients attending diabetes clinics in two sub-urban hospitals: Bono Region, Ghana.

Authors:  Timothy Agandah Abagre; Delia Akosua Bandoh; Adolphina Addoley Addo-Lartey
Journal:  BMC Cardiovasc Disord       Date:  2022-08-10       Impact factor: 2.174

3.  Gender and Age Impacts on the Association Between Thyroid Function and Metabolic Syndrome in Chinese.

Authors:  Zhaowei Meng; Ming Liu; Qing Zhang; Li Liu; Kun Song; Jian Tan; Qiang Jia; Guizhi Zhang; Renfei Wang; Yajing He; Xiaojun Ren; Mei Zhu; Qing He; Shen Wang; Xue Li; Tianpeng Hu; Na Liu; Arun Upadhyaya; Pingping Zhou; Jianping Zhang
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

4.  Does the low-density lipoprotein cholesterol play a key role in predicting metabolic syndrome in the Iranian adult population?

Authors:  Karimollah Hajian-Tilaki; Behzad Heidari; Arefeh Hajian-Tilaki; Alireza Firouzjahi; Afsaneh Bakhtiari
Journal:  Caspian J Intern Med       Date:  2017

5.  The Impact of Education and Age on Metabolic Disorders.

Authors:  Christopher R Stephens; Jonathan F Easton; Adriana Robles-Cabrera; Ruben Fossion; Lizbeth de la Cruz; Ricardo Martínez-Tapia; Antonio Barajas-Martínez; Alejandro Hernández-Chávez; Juan Antonio López-Rivera; Ana Leonor Rivera
Journal:  Front Public Health       Date:  2020-05-20

6.  Prevalence of the Metabolic Syndrome and its determinants among Nepalese adults: Findings from a nationally representative cross-sectional study.

Authors:  Suresh Mehata; Nipun Shrestha; Ranju Kumari Mehta; Bihungum Bista; Achyut Raj Pandey; Shiva Raj Mishra
Journal:  Sci Rep       Date:  2018-10-09       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.